Bufexamac HDAC Inhibitors Bufexamac 2438-72-4 Bufexamac 1353882-38-8
2012年8月1日星期三
Method for treatment of inflammatory disease and disorder
The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using PKC isoform modulators. Exemplary modulators include inhibitors of PKC-alpha, PKC-epsilon and PKC-eta, as well as activators of PKC-delta....
订阅：
博文评论 (Atom)
没有评论:
发表评论